Skip to content

Genetic Analysis of Gray Platelet Syndrome

Genetic Analysis of Gray Platelet Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00069680
Enrollment
123
Registered
2003-09-30
Start date
2003-09-29
Completion date
2018-05-17
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Linkage, Myelofibrosis

Keywords

Gene Identification, Linkage Analysis, Homozygosity Mapping, Gray Platelet Syndrome, GPS, Platelet Function Defect, Bleeding Disorder

Brief summary

This study will identify and characterize the gene or genes responsible for Gray Platelet syndrome (GPS). Platelets are small blood cells that stick on injured blood vessels to form a plug and stop bleeding. When a blood vessel is injured (like a cut on a finger), platelets release the proteins stored in their sacs to help form a blood clot. Patients with GPS bleed longer than other people because their platelets lack some of these protein-carrying sacs. Platelets without sacs look pale gray under the microscope rather than pink, giving the syndrome its name. Except for rare patients with severe hemorrhage, the bleeding tendency in GPS is usually mild to moderate, with patients experiencing easy bruising, nosebleeds, and, in women, excessive menstrual bleeding. Patients with GPS and members of their family with GPS may be eligible for this study. Participants will provide a personal and family medical history and will have blood drawn. About 1 to 2 tablespoons of blood will be drawn in adults, and about 1 teaspoon in children. The blood will be analyzed for genes that cause GPS

Detailed description

Patients with Gray Platelet Syndrome (GPS) and their unaffected family members will be studied to identify the gene(s) involved in GPS using linkage analysis and gene mapping strategies. Up to 200 individual members of GPS families will be investigated to identify candidate regions of the human genome, which will be further studied using fine mapping and sequence analysis. Characterization of gene(s) involved in GPS could provide important insight into the mechanisms of vesicle formation and protein sorting in human cells.

Interventions

None listed

Sponsors

National Human Genome Research Institute (NHGRI)
Lead SponsorNIH

Eligibility

Sex/Gender
ALL
Age
1 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* INCLUSION CRITERIA: Enrollment in this study will be limited to patients diagnosed with GPS and their unaffected relatives. The diagnosis will be based upon absence or marked reduction of platelet Alpha-granules on electron microscopy.

Exclusion criteria

Patients with reduction in both Alpha and Beta granules will be excluded, since this is probably a separate disease.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026